NCT05738694 2026-03-17Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaSun Yat-sen UniversityPhase 3 Recruiting298 enrolled
NCT00715442 2025-12-23Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)M.D. Anderson Cancer CenterPhase 2 Active not recruiting50 enrolled